Pharmacology
News
Monoclonal antibody drops fat, ups muscle in obesity, diabetes
‘Blockade of the activin receptor with bimagrumab could provide a novel pharmacologic approach for managing patients with type 2 diabetes with...
Conference Coverage
COVID-19 risks linked to medications in IBD
Some drugs may lead to worse outcomes, though infection rates appear similar.
News
First monthly injectable HIV treatment approved by FDA
News
ColCORONA: Colchicine reduces complications in outpatient COVID-19
News
Full-dose anticoagulation reduces need for life support in COVID-19
Latest News
Controversy flares over ivermectin for COVID-19
Critics have said there are not enough data to institute a protocol.
News
Monoclonal antibody combo treatment reduces viral load in mild to moderate COVID-19
Bamlanivimab alone in three different single-infusion doses showed no significant reduction in viral load, compared with placebo.
News
ACEIs, ARBs safe to continue in COVID-19: Trial published
Recent data suggest that immune dysfunction may contribute to poor outcomes among COVID-19 patients.
News
Repeated ketamine infusions linked to rapid relief of PTSD
“What was surprising was how robust the results were,” said Dr. Adriana Feder, lead author of the study.
News
Further warning on SGLT2 inhibitor use and DKA risk in COVID-19
Five new cases of euglycemic diabetic ketoacidosis seen in T2D patients with acute COVID-19 illness.